Horizon Pharma PLC (NASDAQ:HZNP)

13.77
BATS BZX Real-Time Price
As of 3:29pm ET
 +0.08 / +0.58%
Today’s Change
9.45
Today|||52-Week Range
16.02
-5.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.6B

Company Description

Horizon Pharma Plc engages in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. The company was founded on December 20, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Horizon Pharma Plc
Connaught House
Dublin Dublin 4
P:(531) 772-2100
Investor Relations:

Employees

Shareholders

Other institutional51.06%
Mutual fund holders36.35%
Individual stakeholders2.22%

Top Executives

Timothy P. WalbertChairman, President & Chief Executive Officer
Paul W. HoelscherChief Financial Officer & Executive Vice President
Jeffrey W. ShermanChief Medical Officer & Executive VP-Research
Michael A. DesJardinExecutive Vice President-Technical Operations
Lin Shao-LeeChief Scientific Officer